XML 42 R30.htm IDEA: XBRL DOCUMENT
v3.25.3

Earnings per Common Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings Per Common Share | The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 175.0 |  |  | $ | 147.8 |  |  | $ | 557.8 |  |  | $ | 435.6 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (48.1) |  |  | (38.9) |  |  | (135.9) |  |  | (97.6) |
Less: Income allocated to participating securities | (0.3) |  |  | (0.7) |  |  | (1.1) |  |  | (2.0) |
Income from continuing operations attributable to Encompass Health common shareholders | 126.6 |  |  | 108.2 |  |  | 420.8 |  |  | 336.0 |
Loss from discontinued operations attributable to Encompass Health common shareholders | (0.4) |  |  | (0.7) |  |  | (1.8) |  |  | (3.2) |
Net income attributable to Encompass Health common shareholders | $ | 126.2 |  |  | $ | 107.5 |  |  | $ | 419.0 |  |  | $ | 332.8 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 100.5 |  |  | 99.9 |  |  | 100.5 |  |  | 99.9 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.26 |  |  | $ | 1.09 |  |  | $ | 4.19 |  |  | $ | 3.36 |
Discontinued operations | — |  |  | (0.01) |  |  | (0.02) |  |  | (0.03) |
Net income | $ | 1.26 |  |  | $ | 1.08 |  |  | $ | 4.17 |  |  | $ | 3.33 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 175.0 |  |  | $ | 147.8 |  |  | $ | 557.8 |  |  | $ | 435.6 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (48.1) |  |  | (38.9) |  |  | (135.9) |  |  | (97.6) |
Income from continuing operations attributable to Encompass Health common shareholders | 126.9 |  |  | 108.9 |  |  | 421.9 |  |  | 338.0 |
Loss from discontinued operations attributable to Encompass Health common shareholders | (0.4) |  |  | (0.7) |  |  | (1.8) |  |  | (3.2) |
Net income attributable to Encompass Health common shareholders | $ | 126.5 |  |  | $ | 108.2 |  |  | $ | 420.1 |  |  | $ | 334.8 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 102.3 |  |  | 102.1 |  |  | 102.3 |  |  | 102.2 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.24 |  |  | $ | 1.07 |  |  | $ | 4.13 |  |  | $ | 3.31 |
Discontinued operations | — |  |  | (0.01) |  |  | (0.02) |  |  | (0.03) |
Net income | $ | 1.24 |  |  | $ | 1.06 |  |  | $ | 4.11 |  |  | $ | 3.28 |
Schedule of Reconciliation of Weighted Average Number of Shares Outstanding | The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Basic weighted average common shares outstanding | 100.5 |  |  | 99.9 |  |  | 100.5 |  |  | 99.9 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.8 |  |  | 2.2 |  |  | 1.8 |  |  | 2.3 |
Diluted weighted average common shares outstanding | 102.3 |  |  | 102.1 |  |  | 102.3 |  |  | 102.2 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration